United States · Compounding pharmacy · Compounded

Strive Pharmacy review

A compounding pharmacy selling semaglutide and tirzepatide combined with glycine and B12 — the additive pattern at the centre of Eli Lilly’s case against it.

Reviewed 2026-08-176/13 checklist items publishedProvider site ↗

Overview

Strive is a compounding pharmacy rather than a telehealth service. It does not prescribe: it fills what a provider sends, across multiple locations, and describes itself as “More than a compounding pharmacy”, on a mission “to flip the personal wellness script”, rejecting “the one-size-fits-all approach to medicine”. It has operated since 2018.

Its GLP-1 products are listed as “Semaglutide/Glycine/B12” and “Tirzepatide/Glycine/B12”, alongside sermorelin, low-dose naltrexone, phentermine and a supplements line. That naming is worth pausing on, because it is exactly the structure the manufacturers are litigating. Compounding is lawful when a medicine is tailored to an individual patient; adding glycine and B12 to a GLP-1 is what makes the product a compound rather than a copy. Lilly’s case is that such additions are a pretext for mass production. Strive’s own framing — rejecting one-size-fits-all — is the opposite argument, made in its own words.

Because Strive sits behind the prescriber rather than in front of the patient, most of our checklist does not apply and it publishes no consumer pricing. If you are buying a compounded GLP-1 from a telehealth service, this is the sort of company that may be filling it — which is precisely why the services that will not name their pharmacy are asking you to skip a check you could otherwise make.

Medications and supply

Compounded, and openly so — this is a compounding pharmacy and does not present itself otherwise. The GLP-1s are sold as combinations with glycine and B12 rather than as the molecule alone, which is the formulation choice that places them inside the compounding exemption and at the centre of the manufacturer litigation.

  • Semaglutide/Glycine/B12 (injection)
  • Tirzepatide/Glycine/B12 (injection)
  • Sermorelin
  • Low-dose naltrexone
  • Phentermine HCl

How the service works

Consultation
None. Strive dispenses against a prescription from your own provider rather than prescribing.
Eligibility
Not stated in the sources we checked.
Provider involvement
Your prescriber, not Strive’s. The site is organised around separate provider and patient paths, with providers sending prescriptions in.
Lab requirements
Not stated in the sources we checked.
Pharmacy fulfilment
Strive is the pharmacy. It operates multiple locations and offers order tracking. We could not establish from the site whether it holds 503A or 503B registration.
Shipping
A shipping policy is published; terms were not readable on the pages we could retrieve.
Support services
Order tracking and a help route for patients and providers.

What it costs

Published prices for Strive Pharmacy
ItemPublished priceNotes
Membership fee
Not stated in the sources we checked.
Medication fee
Not stated in the sources we checked.
Insurance
Not stated in the sources we checked.
HSA / FSA
Not stated in the sources we checked.
Cancellation
Not stated in the sources we checked.
Refunds
A refund policy is published; terms were not readable on the pages we could retrieve.

Pros

  • Does not pretend to be anything but a compounding pharmacy, which is more transparency about its role than several telehealth services offer about theirs.
  • Named and checkable — if your provider uses Strive, you can look it up, which you cannot do with the services that keep their pharmacy anonymous.
  • Operating since 2018 rather than a pandemic-era arrival.
  • Publishes shipping and refund policies and offers order tracking.

Cons

  • A defendant in Eli Lilly’s April 2025 suit over compounded tirzepatide.
  • Sells GLP-1s as glycine and B12 combinations, the formulation the manufacturers argue is a pretext for mass production.
  • No consumer pricing published, because it sells through prescribers.
  • We could not establish whether it is a 503A pharmacy or a 503B outsourcing facility, which is the single most useful fact about a compounder.
  • FDA’s proposal to remove semaglutide and tirzepatide from the 503B bulks list bears directly on businesses like this one.

Who it may suit

Not a direct-to-consumer choice — you reach Strive through a prescriber. It is here so that anyone told their compounded GLP-1 comes from Strive can read what is publicly known about it, including the litigation.

Limitations

  • This is a pharmacy, not a consumer service, so most of our disclosure checklist does not apply and the score should not be compared with telehealth entries.
  • No pricing, eligibility or clinical detail is published for patients, because that sits with the prescriber.
  • We could not confirm 503A or 503B status, or read the shipping and refund terms.
  • We could not verify the current status of the Lilly case against it.

Questions

Can I buy from Strive directly?

No. Strive is a compounding pharmacy and fills prescriptions sent by your own provider. If you are getting compounded semaglutide from a telehealth service, Strive may be the pharmacy behind it.

Why is the product called Semaglutide/Glycine/B12?

Because the additions are what make it a compounded medicine rather than a copy of an approved drug. Compounding is lawful when a medicine is tailored to a patient, and combinations like this are how that tailoring is expressed. Eli Lilly’s case is that such additions are a pretext for mass production; that question has not been settled.

Is Strive being sued?

Yes. Eli Lilly sued Strive and Empower Pharmacy in April 2025 over compounded tirzepatide. Nothing has been proved and we could not verify the current status of the case against Strive specifically.

Is Strive a 503A or 503B facility?

We could not establish that from its site, which is a real gap — it determines what it may lawfully compound and in what quantity, and FDA has proposed removing these molecules from the 503B bulks list entirely.

Sources

Everything on this page traces to one of the links below, retrieved on the date shown. Prices and programme terms in this market change without notice — confirm against the provider before you buy.

  1. 01Strive Pharmacy — product list including Semaglutide/Glycine/B12 and Tirzepatide/Glycine/B12, positioning, locationsretrieved 2026-08-17
  2. 02CNBC — “Eli Lilly sues two pharmacies making copycat Zepbound”, on the April 2025 suits against Strive and Empowerretrieved 2026-08-17